Out-of-Pocket Spending Not Associated with Oral Oncolytic Survival Benefit

BACKGROUND: With total and out-of-pocket spending for oral oncolytics rising, there is increased interest in choosing oncology treatments based on their clinical value relative to cost. OBJECTIVE: To determine if out-of-pocket spending varied for higher versus lower benefit oral oncology drugs reimb...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Manag Care Spec Pharm
Hlavní autoři: Rotenstein, Lisa S., Dusetzina, Stacie B., Keating, Nancy L.
Médium: Artigo
Jazyk:Inglês
Vydáno: Academy of Managed Care Pharmacy 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6052860/
https://ncbi.nlm.nih.gov/pubmed/29799324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18553/jmcp.2018.24.6.494
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky